vs
MVB FINANCIAL CORP（MVBF）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
MVB FINANCIAL CORP的季度营收约是ROCKWELL MEDICAL, INC.的2.0倍（$36.7M vs $18.3M），MVB FINANCIAL CORP净利率更高（0.0% vs -3.0%，领先3.0%），过去两年MVB FINANCIAL CORP的营收复合增速更高（2.8% vs -10.1%）
MVB金融公司是总部位于美国西弗吉尼亚州的金融控股企业，主要提供商业与零售银行服务、财富管理、抵押贷款及存款产品，同时面向金融科技、游戏领域企业提供专项数字银行解决方案，服务覆盖美国中大西洋地区。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
MVBF vs RMTI — 直观对比
营收规模更大
MVBF
是对方的2.0倍
$18.3M
净利率更高
MVBF
高出3.0%
-3.0%
两年增速更快
MVBF
近两年复合增速
-10.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.7M | $18.3M |
| 净利润 | $0 | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | — | -2.2% |
| 净利率 | 0.0% | -3.0% |
| 营收同比 | — | -25.6% |
| 净利润同比 | — | 26.7% |
| 每股收益（稀释后） | $0.39 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MVBFRMTI
| Q1 26 | $36.7M | — | ||
| Q4 25 | $39.1M | $18.3M | ||
| Q3 25 | $61.2M | $15.9M | ||
| Q2 25 | $33.7M | $16.1M | ||
| Q1 25 | $33.7M | $18.9M | ||
| Q4 24 | $46.2M | $24.7M | ||
| Q3 24 | $33.2M | $28.3M | ||
| Q2 24 | $34.7M | $25.8M |
净利润MVBFRMTI
| Q1 26 | $0 | — | ||
| Q4 25 | $4.2M | $-554.0K | ||
| Q3 25 | $17.1M | $-1.8M | ||
| Q2 25 | $2.0M | $-1.5M | ||
| Q1 25 | $3.6M | $-1.5M | ||
| Q4 24 | $9.4M | $-756.0K | ||
| Q3 24 | $2.1M | $1.7M | ||
| Q2 24 | $4.1M | $343.0K |
毛利率MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% |
营业利润率MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | -2.2% | ||
| Q3 25 | 38.3% | -9.9% | ||
| Q2 25 | 9.4% | -8.4% | ||
| Q1 25 | 14.3% | -7.2% | ||
| Q4 24 | 26.5% | -2.1% | ||
| Q3 24 | 8.4% | 6.8% | ||
| Q2 24 | 15.9% | 2.0% |
净利率MVBFRMTI
| Q1 26 | 0.0% | — | ||
| Q4 25 | 10.8% | -3.0% | ||
| Q3 25 | 28.0% | -11.0% | ||
| Q2 25 | 5.9% | -9.3% | ||
| Q1 25 | 10.6% | -8.0% | ||
| Q4 24 | 20.4% | -3.1% | ||
| Q3 24 | 6.3% | 5.9% | ||
| Q2 24 | 11.8% | 1.3% |
每股收益（稀释后）MVBFRMTI
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.32 | $-0.01 | ||
| Q3 25 | $1.32 | $-0.05 | ||
| Q2 25 | $0.15 | $-0.05 | ||
| Q1 25 | $0.27 | $-0.04 | ||
| Q4 24 | $0.72 | $-0.02 | ||
| Q3 24 | $0.16 | $0.04 | ||
| Q2 24 | $0.31 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $334.9M | $37.0M |
| 总资产 | $3.3B | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MVBFRMTI
| Q1 26 | $177.6M | — | ||
| Q4 25 | $244.1M | $10.7M | ||
| Q3 25 | $300.0M | $13.6M | ||
| Q2 25 | $399.4M | $12.5M | ||
| Q1 25 | $251.4M | $11.4M | ||
| Q4 24 | $317.9M | $15.7M | ||
| Q3 24 | $610.9M | $12.3M | ||
| Q2 24 | $455.5M | $11.9M |
股东权益MVBFRMTI
| Q1 26 | $334.9M | — | ||
| Q4 25 | $334.0M | $37.0M | ||
| Q3 25 | $327.8M | $37.0M | ||
| Q2 25 | $302.3M | $30.4M | ||
| Q1 25 | $310.1M | $31.5M | ||
| Q4 24 | $305.7M | $32.6M | ||
| Q3 24 | $303.1M | $29.1M | ||
| Q2 24 | $296.6M | $23.5M |
总资产MVBFRMTI
| Q1 26 | $3.3B | — | ||
| Q4 25 | $3.3B | $57.1M | ||
| Q3 25 | $3.2B | $57.5M | ||
| Q2 25 | $3.2B | $52.6M | ||
| Q1 25 | $3.0B | $54.0M | ||
| Q4 24 | $3.1B | $59.2M | ||
| Q3 24 | $3.4B | $57.1M | ||
| Q2 24 | $3.3B | $53.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.2M |
| 自由现金流率自由现金流/营收 | — | 12.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $2.3M | ||
| Q3 25 | $-2.6M | $-1.3M | ||
| Q2 25 | $7.4M | $1.8M | ||
| Q1 25 | $14.1M | $-3.5M | ||
| Q4 24 | $-285.0K | $865.0K | ||
| Q3 24 | $8.6M | $4.3M | ||
| Q2 24 | $26.9M | $1.4M |
自由现金流MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | $2.2M | ||
| Q3 25 | $-3.5M | $-1.5M | ||
| Q2 25 | $7.2M | $1.7M | ||
| Q1 25 | $13.9M | $-3.5M | ||
| Q4 24 | $-1.9M | $470.0K | ||
| Q3 24 | $8.3M | $4.1M | ||
| Q2 24 | $26.6M | $1.2M |
自由现金流率MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 12.0% | ||
| Q3 25 | -5.8% | -9.6% | ||
| Q2 25 | 21.5% | 10.5% | ||
| Q1 25 | 41.2% | -18.8% | ||
| Q4 24 | -4.1% | 1.9% | ||
| Q3 24 | 25.1% | 14.4% | ||
| Q2 24 | 76.7% | 4.5% |
资本支出强度MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 0.5% | ||
| Q3 25 | 1.6% | 1.4% | ||
| Q2 25 | 0.6% | 1.0% | ||
| Q1 25 | 0.8% | 0.3% | ||
| Q4 24 | 3.5% | 1.6% | ||
| Q3 24 | 0.9% | 0.7% | ||
| Q2 24 | 0.7% | 1.1% |
现金转化率MVBFRMTI
| Q1 26 | — | — | ||
| Q4 25 | 0.95× | — | ||
| Q3 25 | -0.15× | — | ||
| Q2 25 | 3.72× | — | ||
| Q1 25 | 3.95× | — | ||
| Q4 24 | -0.03× | — | ||
| Q3 24 | 4.15× | 2.57× | ||
| Q2 24 | 6.57× | 4.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVBF
| Net Interest Income | $28.5M | 78% |
| Noninterest Income | $8.2M | 22% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
